A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

For patients with HRRm prostate cancer receiving Akeega and Zytiga with prednisone, quality of life remained at baseline.

“You can see that there was an initial reduction in the HR-QOL score in the niraparib arm, which may have been explained by the onset of the most frequently observed adverse events, which included ...

Rathkopf presented the Late-breaking abstract 91 - Patient-reported outcomes (PROs) from AMPLITUDE, a randomized placebo-controlled phase 3 trial of niraparib (NIRA) and abiraterone acetate (AA) plus ...

Niraparib combined with abiraterone acetate and prednisone improved rPFS in mCSPC patients with HRR gene alterations, especially BRCA1/2 mutations. The combination showed potential in reducing ...

What naked mole-rats lack in the looks department they make up for it in longevity, living healthily for nearly four decades.

Scientists discovered four protein changes that help naked mole rats repair DNA faster. These small tweaks may explain their ...

A new international study led by researchers at University College London (UCL) has found that a new drug combination could ...

The fascinating secrets behind the naked mole-rat's extraordinary longevity and how its unique biology could change the ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone ...

The secret to the naked mole-rats' extraordinarily long life may lie in subtle changes to just four amino acids, researchers ...